A detailed history of Fmr LLC transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Fmr LLC holds 10,351,641 shares of LIFE stock, worth $19.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,351,641
Previous 8,923,210 16.01%
Holding current value
$19.3 Million
Previous $17.4 Million 7.2%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.0 - $2.07 $0 - $2.96 Million
1,428,431 Added 16.01%
10,351,641 $16.1 Million
Q1 2024

May 13, 2024

BUY
$1.42 - $2.02 $197,665 - $281,186
139,201 Added 1.58%
8,923,210 $17.4 Million
Q4 2023

Feb 13, 2024

BUY
$1.11 - $1.51 $252,063 - $342,896
227,084 Added 2.65%
8,784,009 $12.4 Million
Q3 2023

Nov 13, 2023

BUY
$1.55 - $2.23 $640,401 - $921,351
413,162 Added 5.07%
8,556,925 $13.5 Million
Q2 2023

Aug 11, 2023

BUY
$1.72 - $2.57 $291,464 - $435,501
169,456 Added 2.13%
8,143,763 $17.6 Million
Q1 2023

May 11, 2023

BUY
$1.88 - $2.5 $6.81 Million - $9.06 Million
3,622,900 Added 83.26%
7,974,307 $16.7 Million
Q4 2022

Feb 13, 2023

BUY
$2.02 - $2.49 $116,455 - $143,550
57,651 Added 1.34%
4,351,407 $9.53 Million
Q3 2022

Nov 10, 2022

BUY
$2.79 - $4.15 $238,040 - $354,073
85,319 Added 2.03%
4,293,756 $12.9 Million
Q2 2022

Aug 12, 2022

BUY
$2.63 - $5.61 $102,748 - $219,171
39,068 Added 0.94%
4,208,437 $11.9 Million
Q1 2022

May 13, 2022

BUY
$4.75 - $7.54 $3,648 - $5,790
768 Added 0.02%
4,169,369 $22.3 Million
Q4 2021

Feb 14, 2022

BUY
$7.29 - $9.5 $767,695 - $1 Million
105,308 Added 2.59%
4,168,601 $31.1 Million
Q3 2021

Nov 15, 2021

BUY
$4.22 - $12.48 $10.1 Million - $29.8 Million
2,387,413 Added 142.46%
4,063,293 $36.9 Million
Q2 2021

Aug 13, 2021

BUY
$3.62 - $4.88 $6.07 Million - $8.18 Million
1,675,880 New
1,675,880 $8.18 Million

Others Institutions Holding LIFE

About aTYR PHARMA INC


  • Ticker LIFE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,625,000
  • Market Cap $53.2M
  • Description
  • aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...
More about LIFE
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.